dr. volkow dr.glas throckmorton, a deputy director of the drug evaluation for the food and drug administration, dr. debra houry, director of the national injury and prevention and control at the centers for disease control and prevention the honorable ms. hyde, and patrick conway, innovation and quality for medicaid and medicare services. welcome. you are aware that the committee is holding an investigative hearing and when doing so has a practice of taking testimony under oath. do you have any objection to testifying under oath? none of the witnesses are -- have objection. the chair advises you under the rules of the house and committee that you're entitled to be advised by counsel. none of the witnesses say so. so in that case, please rise raise your right hand, i'll swear you in. do you swear that the testimony you're about to give is the truth, the whole truth, and nothing but the truth? >> yes. >> thank you. all witnesses answered in the affirmative. you are now under oath. and subject to the p

dr. volkow.we talked about how the opioid addiction facing the country is in large part due to chronic pain. you mentioned 100 million people suffer from chronic pain. one in i heard up to one in three americans possibly suffer from chronic pain. one of the goals of this hearing is to focus on evidence-based treatment and new treatments, try to find out what is working and obviously one treatment doesn't work for everyone as we've heard. but there is, i learned about in the course of examining this, that there are technologies that are new, not completely new, one being -- i was told about spinal cord stimulation which targets nerves with electrical impulses rather than drugs. clinical studies show it to be safe, 4,000 patients received the stimulator, so it obviously is a device, a technology, that can actually stop that stimulation, it can help hopefully end that addiction, yet nih hasn't included it in the draft pain strategy, didn't mention technologies like scs. can you talk at all about why

dr. volkow. we talked about how the opioid addiction facing the country is in large part due to chronic pain. you mentioned 100 million people suffer from chronic pain. one in i heard up to one in three americans possibly suffer from chronic pain. one of the goals of this hearing is to focus on evidence based treatment and new treatments, try to find out what is working and obviously one treatment doesn't work for everyone as we heard. but there is, i learned about in the course of examining this that there are technologies that are new, not completely new, one being -- i was told about spinal cord stimulation which targets nerves with electrical impulses rather than drugs. clinical studies show it to be safe, 4,000 patients received the stimulator, so it obviously is a device, a technology that can actually stop that stimulation, it can help hopefully end that addiction yet nih hasn't included it in the draft pain strategy, didn't mention technologies like scs. can you talk at all about why it w

dr. volkow. we talked about how the opioid addiction facing the country is in large part due to chronic pain come and she mentioned 109 people suffer from chronic pain. i heard up to one in three americans actually, possibly suffer from chronic pain. and one of the goals of this is a tighter evidence-based treatment and new treatments and try to find out what it is that is working. and i visit one treatment doesn't work for everyone as we for. but it is compelling about in the course of examining this that are some technologies that are new not completely new but one thing i was told about spinal cord stimulation which targets and nerves with electrical impulses rather than drugs and that clinical studies that showed it to be safe than 4000 patients have received the stimulator. so it obviously is a device technology that can actually stop the stimulation and can help hopefully end of that addiction but yet nah hasn't concluded that in its draft and strategy to get didn't mention technologies lik

dr. nora volkow, director of the national institute of drug abuse as a nation institute of health. dr. douglas throckmorton, nobody director for the center for drug evaluation and research for the food and drug administration. doctor debra houry comfort to the national center for injury and prevention and control of essential disease control and prevention. the honorable pamela hyde come administered for substance abuse and mental health administration. dr. patrick conway, deputy administrator for innovation and quality and seen as chief medical officer for cms. welcome. >> as you are aware i went elsewhere in the witnesses, the committee is holding an investigative hearing and when doing so as a practice to give testimony under oath. do you have any objection to testifying under oath? none of the witnesses have objection. a chair with an advisor to the rules of the house on both the committee on title ii device by council. if you use advice to be -- none of the witnesses say so. in that case please rise raise your right hand and i will swear you in. [witnesses were sworn in] >> thank

dr. nora volkow with the national institutes of health. dr. douglas throckmorton, the food and drug administration. dr. deborah houry, for injury and prevention for the centers for disease control and prevention. dr. hyde. and dr. conway from medicare and medicaid services. welcome. the committee has a practice of taking testimony under oath. do you have any objection to testifying under oath? none of the witnesses have objection. the chair would then advise you under the rules of the house and committee you're entitled to be advised by counsel. do any of you desire to be advised by counsel? none of the witnesses say so. in that case, please rise and raise your right hand. i'll swear you in. do you swear that the testimony you're about to give is the truth, the whole truth, and nothing but the truth? thank you all. all the witnesses answered in the affirmative. you are now under oath and subject to the penalties set forth in title 18 section 1, 001 of the united states code. you may now each give a five-minute opening statement. please stick t